Adherium (ASX:ADR) Interest Expense (Positive)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:ADR Adherium Ltd ASX:ADR
5 GF Score
Price A$0.11
GF Value A$0.34
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Adherium Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

ASX:ADR
5GF Score
Adherium Ltd ASX:ADR
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adherium (ASX:ADR) Overvalued in 2026?

Based on GuruFocus' analysis, Adherium stock appears to be undervalued. The current stock price of A$0.11 is trading 67.6% below its estimated GF Value™ of A$0.34. GuruFocus considers Adherium to be Possible Value Trap.

Key valuation signals for ASX:ADR:

  • Interest Expense (Positive):
  • GF Value™: A$0.34 vs. price of A$0.11 (67.6% below fair value)
  • GF Score™: 5/100 with 8 warning signs

No single metric tells the full story. See the ASX:ADR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adherium Business Description

Other Exchanges ADRMF:USA
Address 447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, North America, and Asia. The majority of its revenue comes from Europe.
5GF Score

Get the complete analysis for ASX:ADR

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price
A$0.34
GF Value